Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV000852127 | SCV000899735 | likely pathogenic | Factor VII deficiency | 2019-02-01 | criteria provided, single submitter | research | |
Baylor Genetics | RCV000852127 | SCV001522607 | likely pathogenic | Factor VII deficiency | 2020-05-06 | criteria provided, single submitter | clinical testing | This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV001561212 | SCV001783767 | likely pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 9680360, 8652821, 25525159, 31273093, 31064749, 29318701, 25952977) |
Hudson |
RCV002245657 | SCV002515848 | pathogenic | Congenital factor VII deficiency | 2022-04-21 | criteria provided, single submitter | research | ACMG codes: PVS1, PS3, PM2 |
Fulgent Genetics, |
RCV002487577 | SCV002779130 | pathogenic | Myocardial infarction, susceptibility to; Congenital factor VII deficiency | 2024-01-16 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001561212 | SCV004224395 | pathogenic | not provided | 2022-04-01 | criteria provided, single submitter | clinical testing | PM2, PS3, PS4_moderate, PVS1 |